Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;42(2):78-81.
doi: 10.4103/0253-7613.64501.

Effect of ascorbic acid supplementation on nitric oxide metabolites and systolic blood pressure in rats exposed to lead

Affiliations

Effect of ascorbic acid supplementation on nitric oxide metabolites and systolic blood pressure in rats exposed to lead

Amani Mohammad et al. Indian J Pharmacol. 2010 Apr.

Abstract

Background: Extended exposure to low levels of lead causes high blood pressure in human and laboratory animals. The mechanism is not completely recognized, but it is relatively implicated with generation of free radicals, oxidant agents such as ROS, and decrease of available nitric oxide (NO). In this study, we have demonstrated the effect of ascorbic acid as an antioxidant on nitric oxide metabolites and systolic blood pressure in rats exposed to low levels of lead.

Materials and methods: The adult male Wistar rats weighing 200-250 g were divided into four groups: control, lead acetate (receiving 100 ppm lead acetate in drinking water), lead acetate plus ascorbic acid (receiving 100 ppm lead acetate and 1 g/l ascorbic acid in drinking water), and ascorbic acid (receiving 1 g/l ascorbic acid in drinking water) groups. The animals were anesthetized with ketamin/xylazine (50 and 7 mg/kg, respectively, ip) and systolic blood pressure was then measured from the tail of the animals by a sphygmomanometer. Nitric oxide levels in serum were measured indirectly by evaluation of its stable metabolites (total nitrite and nitrate (NOchi)).

Results: After 8 and 12 weeks, systolic blood pressure in the lead acetate group was significantly elevated compared to the control group. Ascorbic acid supplementation could prevent the systolic blood pressure rise in the lead acetate plus ascorbic acid group and there was no significant difference relative to the control group. The serum NOchi levels in lead acetate group significantly decreased in relation to the control group, but this reduction was not significantly different between the lead acetate plus ascorbic acid group and the control group.

Conclusion: Results of this study suggest that ascorbic acid as an antioxidant prevents the lead induced hypertension. This effect may be mediated by inhibition of NOchi oxidation and thereby increasing availability of NO.

Keywords: Blood pressure; ascorbic acid; lead; nitric oxide.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

Figures

Figure 1
Figure 1
Animal weights in different groups. (CNTL: control group; AA: ascorbic acid group; Ld: lead acetate group; Ld+AA: lead acetate + ascorbic acid group)
Figure 2
Figure 2
The serum ascorbic acid concentration on 12th week
Figure 3
Figure 3
Measurement of systolic blood pressure (Mean ± SEM, N=7)
Figure 4
Figure 4
Measurement of NOχ concentration (Mean ± SEM, N=7)

Similar articles

Cited by

References

    1. Sharp DS, Becker CE, Smith AH. Cronic low-level lead exposure: Its role in the pathogenesis of hypertension. Med Toxicol. 1987;2:210–32. - PubMed
    1. Harlan WR. The relationship of blood lead levels to blood pressure in the US population. Environ Health Perspect. 1988;78:9–13. - PMC - PubMed
    1. Vaziri ND. Pathogenesis of lead-induced hypertension: Role of oxidative stress. J Hypertension. 2002;20:15–20. - PubMed
    1. NI Z, Hou S, Barton CH, Vaziri ND. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney Int. 2004;66:2329–36. - PubMed
    1. Ding Y, Gonick HC, Vaziri ND. Lead-induced hypertension: Increased hydroxyl radical production. Am J Hypertens. 2001;14:169–73. - PubMed